MERSILENE POLYESTER FIBER SUTURE UNKNOWN PRODUCT
Report
- Report Number
- 2210968-2023-00093
- Event Type
- Injury
- Date Received
- January 5, 2023
- Date of Event
- January 1, 2021
- Manufacturer
- ETHICON INC.
- Product Code
- GAT
- PMA / PMN Number
- K946173
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- OTHER
Narratives
(B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ANY OF THE ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? WHICH SPECIFIC ETHICON PRODUCTS HAVE BEEN USED DURING THE PROCEDURES (PRODUCT CODE, LOT NUMBER)? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH ANY OF THE ETHICON PRODUCTS USED IN THIS PROCEDURE? IF SO, PLEASE PROVIDE DETAILS. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PATIENT DEMOGRAPHICS? THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. (B)(4). THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS. THERE ARE NO ADDITIONAL DETAILS REGARDING THE ADDITIONAL EVENTS. CITATION: ACTA OPHTHALMOLOGICA 2021: 99: E109¿E116. DOI: 10.1111/AOS.14528.
TITLE: PNEUMATIC RETINOPEXY PRECEDED BY DRAINAGE OF SUBRETINAL FLUID FOR THE TREATMENT OF SEVERE BULLOUS RETINAL DETACHMENT. THIS PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY AIMED TO COMPARE THE EFFICACY AND SAFETY OUTCOMES OF SCLERAL BUCKLING (SB) AND DRAINAGE¿INJECTION¿PNEUMORETINOPEXY (DIP), A MODIFIED PNEUMATIC RETINOPEXY TECHNIQUE, IN WHICH, BEFORE GAS INJECTION, SUBRETINAL FLUID IS DRAINED WITH A SIMULTANEOUS INJECTION OF BALANCED SALT SOLUTION (BSS) IN THE VITREOUS CHAMBER, FOR THE TREATMENT OF SEVERE SUPERIOR BULLOUS RHEGMATOGENOUS RETINAL DETACHMENT (SBRD). A TOTAL OF 58 EYES IN 58 PATIENTS WITH SBRD WHO UNDERWENT SB (N=27; 9 WERE FEMALES; MEAN AGE OF 50.6 (13.2) YEARS ) OR DIP (N=27; 11 WERE FEMALES; MEAN AGE OF 51 (11.8) YEARS) BETWEEN MARCH 2017 AND MARCH 2019 WERE INCLUDED. THE 5-0 MERSILENE SUTURE WAS USED IN SCLERAL BUCKLING (SB) GROUP TO SUTURE THE 2-MM-WIDTH SILICONE ENCIRCLING BAND TO THE FOUR QUADRANTS OF THE SCLERA. THE VICRYL 6-0 THREAD WAS USED IN DIP GROUP, PASSING THROUGH THE SCLERA, TO FACILITATE SURGICAL MANOEUVRES. REPORTED COMPLICATIONS INCLUDE: IN SB GROUP - DIPLOPIA (N=3); MILD POSTOPERATIVE PTOSIS (N=2) WHICH WAS DUE TO A RADIAL SEGMENTAL BUCKLE (SILICON TIRES) THAT HAD BEEN PLACED IN THE UPPER SECTORS: THE TRACTION EXERTED BY THE SURGICAL MANOEUVRES ON THE UPPER RECTUS MUSCLE MIGHT HAVE CAUSED A WEAKENING OF THE UPPER EYELID LEVATOR MUSCLE; AND UNINTENTIONAL PERFORATION OF THE SCLERA DURING THE SUTURE OF THE BUCKLE (N=2) IN CONCLUSION, THEIR FINDINGS SUGGESTED THAT BOTH SB AND DIP ARE SAFE AND EFFECTIVE TREATMENTS YIELDING FUNCTIONAL AND ANATOMICAL RECOVERY IN PATIENTS WITH SEVERE SBRD. HOWEVER, THE DIP TECHNIQUE MAY BE EASIER AND LESS COSTLY, WITH A SUCCESS RATE SIMILAR TO THAT OF SB.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1645483 | MERSILENE POLYESTER FIBER SUTURE UNKNOWN PRODUCT | SUTURE, NONABSORBABLE, SYNTHETIC | GAT | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Other |